You Position: Home > Paper

A Clinical Study on the Level of Lymphocyte Sub-population and NK Cell in Patients with Primary Lung Malignant Tumor and COPD Patients

( views:218, downloads:4 )
Author:
No author available
Journal Title:
JOURNAL OF CHINESE PHYSICIAN
Issue:
8
DOI:
10.3760/cma.j.issn.1008-1372.2004.08.002
Key Word:
淋巴细胞亚群;原发性肺部恶性肿瘤;慢性阻塞性肺部疾病

Abstract: 目的探讨原发性肺部恶性肿瘤与慢性阻塞性肺部疾病(COPD)患者外周血淋巴细胞亚群及NK细胞水平测定的临床价值.方法应用单克隆抗体-碱性磷酸酶抗碱性磷酸酶法(APAAP法)测定60例COPD病人,50例原发性肺部恶性肿瘤病人和40例正常对照组CD3+,CD4+,CD8+,CD19+及NK细胞的百分数,计算CD4+/CD8+比值.结果原发性肺部恶性肿瘤组、COPD组的CD3+,CD4+,CD4+/CD8+,CD19+明显降低,而CD8明显增高,与对照组比较均有显著差异(P<0.01);原发性肺部恶性肿瘤组的NK细胞的百分数降低,与对照组比较有显著差异(P<0.01),COPD组NK表达与对照组比较无显著差异(P>0.05).原发性肺部恶性肿瘤组与COPD组的CD3+,CD4+,CD8+均无明显差异(P>0.05),而NK,CD19+有差异(P<0.01). 结论原发性肺部恶性肿瘤组和COPD组存在细胞免疫功能紊乱和失调,临床上应不失时机的应用免疫调节剂.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn